The withdrawal of the United Kingdom from the Union would, in the absence of a derogation from the applicable rules, thus have the effect that the unique identifiers must be decommissioned for medicinal products intended to be distributed in the United Kingdom.
Recital 5, Regulation (EU) 2021/457
In forcesince 13 Jan 2021